Advancements in Pharmacogenomic Testing: Implications for Drug Development
“The future of medicine is personalized, predictive, and preventive.” – Dr. Francis Collins, Director of the National Institutes of Health1 Pharmacogenomics, a discipline…
“The future of medicine is personalized, predictive, and preventive.” – Dr. Francis Collins, Director of the National Institutes of Health1 Pharmacogenomics, a discipline…
Despite the rapid evolution of genetic technologies, the integration of genomic insights to alleviate health disparities in underprivileged communities remains a pressing area…
The Institute of Medicine reveals that one-third of the U.S. population grapples with persistent pain, underscoring a critical public health issue that necessitates…
The COVID-19 pandemic has posed unprecedented challenges, prompting a critical inquiry: Might our genetic makeup hold the key to more effective treatments in…
In the realm of medical research, a novel domain has surfaced – “omics.” It encompasses the in-depth study of biological molecules, including genes,…
Explore the synergy between PGx and the Microbiome to unlock the secrets of gut health’s role in shaping personalized drug responses.
Unlock personalized medicine with PGx Testing – revolutionizing drug development and optimizing clinical trials for tailored treatments.
Explore how Polygenic Risk Scores enhance personalized medicine by predicting medication side effects and disease susceptibility.
Explore the benefits of Non-Molecular Based Pharmacogenomics Testing for tailored drug therapy that aligns with your unique genetic profile.
Discover how CYP2C9 genetic variations impact warfarin sensitivity and can guide personalized anticoagulant therapy for better patient outcomes.
End of content
End of content
Join Our Insider’s Circle! Stay up to Date with the latest in PGx